Viridian Therapeutics, Inc.\DE

Yiheng Capital Management, L.P. VRDN

Report date

12/31/2025

Quarter

2025 Q4

Filed

2/17/2026

Shares

208,735

Value ($000)

6,496

Weight

2.8%

2025 Q2 - 2025 Q4 (3 filings)

Shares History

History scope: non-option holdings only (PUT/CALL rows excluded).

All 13F Holders	Filing date	Value ($000s)	% of Holdings	Shares	Reporting period
2025 Q4	2/17/2026	6,496	2.8%	208,735	12/31/2025
2025 Q3	11/14/2025	10,796	3.6%	500,261	9/30/2025
2025 Q2	8/14/2025	6,994	2.5%	500,261	6/30/2025